• Info
  • Insider Ownership

Insider Trading & Ownership of Lawrence Otto Klein

Location
Menlo Park, CA
Summary
The estimated net worth of Lawrence Otto Klein is at least $28,388,472 dollars as of 23 Jan 2026. Lawrence Otto Klein is the Chief Executive Officer, Director of Oruka Therapeutics, Inc. and owns shares of Oruka Therapeutics, Inc. (ORKA) stock worth about $28.16M. Lawrence Otto Klein is the Director of Aerovate Therapeutics, Inc. and owns shares of Jade Biosciences, Inc. (JBIO) stock worth about $229.3K.
Signature
/s/ Paul Quinlan, as attorney-in-fact for Lawrence Klein
All Insider Reports
All Insider Reports

Notify me when Lawrence Otto Klein files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Lawrence Otto Klein

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ORKA Oruka Therapeutics, Inc. Chief Executive Officer, Director $28,159,141 23 Jan 2026
JBIO Aerovate Therapeutics, Inc. Director $229,331 29 Apr 2025
CRSP CRISPR Therapeutics AG Cbo & Coo 16 Aug 2022
DYN Dyne Therapeutics, Inc. Director 05 Jul 2022
JSPR, JSPRW Jasper Therapeutics, Inc. Director 07 Jun 2023

Insider Transactions Reported by Lawrence Otto Klein:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.